VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Flavoring Agents
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer.
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. 2021 01 21; 184(2):384-403.e21.
View in:
PubMed
subject areas
Adaptive Immunity
Animals
Apoptosis
Cell Line, Tumor
Cytoplasm
Female
Gene Amplification
Humans
Immunity
Introns
Mice
Molecular Targeted Therapy
Proto-Oncogene Proteins c-myc
RNA Splicing
RNA, Double-Stranded
Signal Transduction
Spliceosomes
Triple Negative Breast Neoplasms
authors with profiles
THOMAS WESTBROOK
JEFFREY ROSEN
KRISTEN MEERBREY
ANNA MALOVANNAYA
DAMIAN YOUNG
SRINIVAS CHAMAKURI
JITENDRA MEENA
GEORGE MILES
MICHAEL LEWIS
XIANG ZHANG
LUKAS SIMON